HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Su, R.-C. Articles by Miller, R. G. Search for Related Content PubMed PubMed Citation Articles by Su, R.-C. Articles by Miller, R. G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Stability of Surface H-2K^b, H-2D^b, and Peptide-Receptive H-2K^b on Splenocytes¹

Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

We have used flow cytometry to study the stability and peptide-binding capability of MHC class I (MHC-I) on the surface of normal C57BL/6 mouse T lymphoblasts. The MHC-I molecules on each cell are nearly evenly divided into two populations with mean half-life values of 1 and 20 h. Our observations suggest that members of the later contain peptide bound with medium to high affinity. Cell surface MHC-I molecules capable of binding exogenous peptide (thus, "peptide-receptive") belong almost entirely to the less stable population. Before exogenous peptide can bind, MHC-I must undergo a change, probably loss of a very low affinity peptide. For MHC-I-K^b, we found that the maximum rate for binding of exogenous peptide corresponds to a t_1/2 value of 12 min. To maintain the 50:50 steady-state distribution of long- vs short-lived MHC-I molecules on the cell surface, 20 short-lived molecules must be exported to the cell surface for each long-lived molecule.

This article has been cited by other articles:

				J. A. Hiss, A. Bredenbeck, F. O. Losch, P. Wrede, P. Walden, and G. Schneider Design of MHC I stabilizing peptides by agent-based exploration of sequence space Protein Eng. Des. Sel., March 1, 2007; 20(3): 99 - 108. [Abstract] [Full Text] [PDF]

				J. J. Ladasky, S. Boyle, M. Seth, H. Li, T. Pentcheva, F. Abe, S. J. Steinberg, and M. Edidin Bap31 Enhances the Endoplasmic Reticulum Export and Quality Control of Human Class I MHC Molecules J. Immunol., November 1, 2006; 177(9): 6172 - 6181. [Abstract] [Full Text] [PDF]

				S. N. Mueller, C. M. Jones, A. T. Stock, M. Suter, W. R. Heath, and F. R. Carbone CD4+ T Cells Can Protect APC from CTL-Mediated Elimination. J. Immunol., June 15, 2006; 176(12): 7379 - 7384. [Abstract] [Full Text] [PDF]

				L. A. Benoit, J. Shannon, J. W. Chamberlain, and R. G. Miller Influence of Xenogeneic {beta}2-Microglobulin on Functional Recognition of H-2Kb by the NK Cell Inhibitory Receptor Ly49C J. Immunol., September 15, 2005; 175(6): 3542 - 3553. [Abstract] [Full Text] [PDF]

				T. Kambayashi, J. R. Kraft-Leavy, J. G. Dauner, B. A. Sullivan, O. Laur, and P. E. Jensen The Nonclassical MHC Class I Molecule Qa-1 Forms Unstable Peptide Complexes J. Immunol., February 1, 2004; 172(3): 1661 - 1669. [Abstract] [Full Text] [PDF]

				B. Kessler, X. Hong, J. Petrovic, A. Borodovsky, N. P. Dantuma, M. Bogyo, H. S. Overkleeft, H. Ploegh, and R. Glas Pathways Accessory to Proteasomal Proteolysis Are Less Efficient in Major Histocompatibility Complex Class I Antigen Production J. Biol. Chem., March 14, 2003; 278(12): 10013 - 10021. [Abstract] [Full Text] [PDF]

				G. Rappocciolo, J. Birch, and S. A. Ellis Down-regulation of MHC class I expression by equine herpesvirus-1 J. Gen. Virol., January 1, 2003; 84(2): 293 - 300. [Abstract] [Full Text] [PDF]

				M. C. Ramirez and L. J. Sigal Macrophages and Dendritic Cells Use the Cytosolic Pathway to Rapidly Cross-Present Antigen from Live, Vaccinia-Infected Cells J. Immunol., December 15, 2002; 169(12): 6733 - 6742. [Abstract] [Full Text] [PDF]